Achromatopsia is an autosomal recessive condition, characterised by reduced visual acuity,
impaired colour vision, photophobia and nystagmus. The symptoms can be profoundly …

Purpose: To perform deep phenotyping of subjects with PDE6C achromatopsia and examine
disease natural history. Methods: Eight subjects with disease-causing variants in PDE6C …

Purpose: To investigate retinal structure in subjects with CNGA3-associated achromatopsia
and evaluate disease symmetry and intrafamilial variability. Methods: Thirty-eight …

Methods: Fifty molecularly confirmed ACHM subjects underwent serial spectral-domain
optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF) imaging. Foveal …

… Author links open overlay panel Michel Michaelides 1 2 , Nashila Hirji 2 , Sui Chien Wong
2 3 , Cagri G. Besirli 4 , Serena Zaman 1 2 , Neruban Kumaran 2 5 , Anastasios Georgiadis 6 , …

Purpose: The purpose of this study was to report GNAT2-associated achromatopsia (GNAT2-ACHM)
natural history, characterize photoreceptor mosaic, and determine a therapeutic …

Methods: Subjects with molecularly confirmed ACHM were recruited in a prospective cohort
study of mesopic microperimetry. Coefficient of repeatability and intraclass correlation …

Recent advances in regenerative therapy have placed the treatment of previously incurable
eye diseases within arms’ reach. Achromatopsia is a severe monogenic heritable retinal …

Aspartate is released in the brain during metabolic inhibition and can activate NMDA
receptors. We compared the characteristics of aspartate and glutamate release mediated by …

Background Carbonic anhydrase inhibitors (CAIs) are frequently used as an initial step to
treat retinitis pigmentosa-associated cystoid macular oedema (RP-CMO). Interestingly, it has …